Search | Médecins Sans Frontières Access Campaign

42 results found

Letter |

19 May 2016

Letter to US Congress - suggestions to fix the FDA PRV for neglected diseases

Tags Research and development neglected diseases access to medicinesFDA priority review voucherinnovationresearch and development (R&D)

Letter |

19 November 2015

Open Letter to the U.S. Senate HELP Committee Leadership: Suggestions to Fix the FDA PRV for Neglected Diseases

Tags Tropical & neglected diseases neglected diseases innovationresearch and development (R&D) United States of America

Simphiwe holds his medication, he takes up to 26 pills a day to treat XDR-TB. Here he holds his morning selection, which includes delamanid, one of the newest DR-TB drugs, which Simphiwe is taking for the first time today.

Opinion article |

18 June 2015

A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health Importance

Tags Research and development antimicrobial resistanceneglected diseases patent oppositionresearch and development (R&D) DNDi

Feature story |

08 December 2014

Congress should fix the priority review voucher program: MSF’s Rius explains

Tags Research and development neglected diseases access to medicinesFDA priority review voucherinnovationresearch and development (R&D)

Statement |

31 January 2014

MSF responds to news of pull out of neglected disease R&D by AstraZeneca

Tags Research and development malarianeglected diseasestuberculosis research and development (R&D) BayerPHARMACEUTICAL CompaniesAstraZeneca

Speech |

25 January 2013

MSF Intervention on Neglected Tropical Diseases at 132nd WHO Executive Board

Tags Intellectual property and tradeTropical & neglected diseases neglected diseasesvisceral leishmaniasis (kala azar) research and development (R&D) World Health Organization

Video |

17 January 2013

Pushing For More R&D For Neglected Diseases

Tags Intellectual property and tradeResearch and developmentTropical & neglected diseases neglected diseases research and development (R&D)

Feature story |

19 December 2012

Looking Ahead to 2013 with MSF's Dr Manica Balasegaram

Tags HIV/AIDSIntellectual property and tradeResearch and developmentTropical & neglected diseasesTuberculosisVaccines HIV/AIDSneglected diseasestuberculosis vaccines research and development (R&D) Novartis Novartis Drop the Case Campaign

Video |

17 December 2012

Medicines Shouldn't be a Luxury

Medicines are essential for health and survival. But far too often, they’re priced like luxury items. We’re working to change that.

Tags HIV/AIDSIntellectual property and tradeResearch and developmentTropical & neglected diseasesTuberculosisVaccines drug-resistant TBHIV/AIDSneglected diseasestuberculosis research and development (R&D)

Video |

13 December 2012

Kala Azar: Still Waiting

Tags Intellectual property and tradeResearch and developmentTropical & neglected diseases neglected diseasesvisceral leishmaniasis (kala azar) research and development (R&D) Sudan

Video |

13 December 2012

Sleeping Sickness: The Long Road

Tags Intellectual property and tradeResearch and developmentTropical & neglected diseases neglected diseasessleeping sickness research and development (R&D)

Press release |

12 December 2012

Millions of Patients Still Waiting for Medical “Breakthroughs” Against Neglected Diseases

Tags HIV/AIDSIntellectual property and tradeResearch and developmentTropical & neglected diseasesTuberculosisVaccines neglected diseasessleeping sicknessvisceral leishmaniasis (kala azar) research and development (R&D)

Report |

12 December 2012

Medical Innovation for Neglected Patients

Tags Intellectual property and tradeResearch and development neglected diseases CEWGresearch and development (R&D) World Health Organization

Video |

12 December 2012

Fatal Neglect: The Global Health Revolution's Forgotten Patients

Tags Research and developmentTropical & neglected diseases sleeping sicknessvisceral leishmaniasis (kala azar)neglected diseasesChagas disease research and development (R&D)

Events |

11 December 2012

Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations

Tags HIV/AIDSIntellectual property and tradeResearch and developmentTropical & neglected diseasesTuberculosisVaccines drug-resistant TBHIV/AIDSneglected diseasessleeping sicknesstuberculosisvisceral leishmaniasis (kala azar) vaccines research and development (R&D)

Opinion article |

06 December 2012

Stuck in a time warp: WHO-brokered global R&D action plan shelved

Tags Intellectual property and tradeResearch and developmentTropical & neglected diseases neglected diseases CEWGresearch and development (R&D) DNDiWorld Health Organization

Press release |

03 December 2012

MSF response to the launch of the G-FINDER report

Tags Intellectual property and tradeResearch and developmentTropical & neglected diseases neglected diseasessleeping sicknessvisceral leishmaniasis (kala azar) research and development (R&D) World Health Organization

A young woman who is suspected of having sleeping sickness is given a second test to be diagnosed.

Feature story |

15 August 2012

Treating sleeping sickness still a challenge in Central African Republic

Tags Research and developmentTropical & neglected diseases neglected diseasessleeping sickness diagnostic testsresearch and development (R&D) Central African Republic

Press release |

11 June 2012

Neglected Tropical Diseases: New MSF Report Highlights How to Break the Cycle of Neglect

Tags Intellectual property and tradeResearch and developmentTropical & neglected diseases sleeping sicknessvisceral leishmaniasis (kala azar)neglected diseases research and development (R&D)

Report |

11 June 2012

Fighting Neglect

Tags Tropical & neglected diseases sleeping sicknessvisceral leishmaniasis (kala azar)neglected diseases research and development (R&D)

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

Letter to US Congress - suggestions to fix the FDA PRV for neglected diseases

Open Letter to the U.S. Senate HELP Committee Leadership: Suggestions to Fix the FDA PRV for Neglected Diseases

A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health Importance

Congress should fix the priority review voucher program: MSF’s Rius explains

MSF responds to news of pull out of neglected disease R&D by AstraZeneca

MSF Intervention on Neglected Tropical Diseases at 132nd WHO Executive Board

Pushing For More R&D For Neglected Diseases

Looking Ahead to 2013 with MSF's Dr Manica Balasegaram

Medicines Shouldn't be a Luxury

Kala Azar: Still Waiting

Sleeping Sickness: The Long Road

Millions of Patients Still Waiting for Medical “Breakthroughs” Against Neglected Diseases

Medical Innovation for Neglected Patients

Fatal Neglect: The Global Health Revolution's Forgotten Patients

Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations

Stuck in a time warp: WHO-brokered global R&D action plan shelved

MSF response to the launch of the G-FINDER report

Treating sleeping sickness still a challenge in Central African Republic

Neglected Tropical Diseases: New MSF Report Highlights How to Break the Cycle of Neglect

Fighting Neglect